Biological markers predictive of anticancer response to insulin-like growth factor-1 receptor kinase inhibitors

Details for Australian Patent Application No. 2011223655 (hide)

Owner OSI Pharmaceuticals, LLC

Inventors Buck, Elizabeth A.; Barr, Sharon M.; Miglarese, Mark R.

Agent Spruson & Ferguson

Pub. Number AU-A-2011223655

PCT Pub. Number WO2011/109584

Priority 61/310,038 03.03.10 US

Filing date 3 March 2011

Wipo publication date 9 September 2011

International Classifications

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

28 June 2012 PCT application entered the National Phase

  PCT publication WO2011/109584 Priority application(s): WO2011/109584

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223657-System and methods of tissue microablation using fractional treatment patterns

2011223654-Bottom-up optimized search system and method